PCG
GBIO

Private Capital Group’s Generation Bio GBIO Stock Holding History

Private Capital Group’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-17
Closed -$5K – 2168
2021
Q2 		$5K Hold
17
– – ﹤0.01% 1554
2021
Q1 		$5K Buy
+17
New +$5.44K ﹤0.01% 1499

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

Private Capital Group's GBIO Position: Q3 2021 in Review

Private Capital Group sold out of Generation Bio (GBIO) in Q3 2021, closing a stake of 17 shares — an estimated $5K sold.

Private Capital Group first reported a position in GBIO in Q1 2021 and held it in 2 quarters. The position peaked at $5K in Q2 2021. 81 funds tracked by Wall St. Rank hold GBIO as of Q3 2021.

  • Private Capital Group reported no remaining Generation Bio position as of Q3 2021 after selling out during the quarter.
  • Private Capital Group sold 17 Generation Bio shares in Q3 2021, an estimated $5K.
  • Private Capital Group first reported a position in Generation Bio in Q1 2021 and held it in 2 quarters.
  • Private Capital Group's Generation Bio position peaked at $5K in Q2 2021.
  • 81 funds tracked by Wall St. Rank held Generation Bio as of Q3 2021.

Based on Private Capital Group's 13F filing for Q3 2021, filed 13 Oct 2021.